Official registry condition

Myocardial Infarction peptide trials

5 selected ClinicalTrials.gov records carrying the official condition label Myocardial Infarction. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

5 selected records.

Connected peptides

3 profiles.

Registry update years

2012–2021 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 78 selected PubMed records and 30 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Myocardial Infarction unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT01438086

PeptideScanner retained ClinicalTrials.gov record NCT01438086 at 2026-11-16T17:35:13.282Z. Its registry update date was 2017-03-30, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
March 30, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00111566

PeptideScanner retained ClinicalTrials.gov record NCT00111566 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-11-28, and PeptideScanner's reviewed identity mapping was eptifibatide.

PeptideScanner change date
November 15, 2026
Cited source date
November 28, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00373451

PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 8, 2012
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →